Literature DB >> 11402021

Characterization of an N-terminally truncated cyclin A isoform in mammalian cells.

H Kaufmann1, R Marone, M A Olayioye, J E Bailey, M Fussenegger.   

Abstract

Cyclin A is essential for regulating key transitions in the eukaryotic cell cycle including initiation of DNA replication and mitosis. This paper describes the characterization of a truncated cyclin A isoform (cyclin A(t)) in vitro in cultured mammalian cells and in mouse tissues. The presence of cyclin A(t) in specific cell types correlates with the ability of cell extracts to cleave in vitro translated cyclin A. In CHO-K1 cells, cyclin A processing to cyclin A(t) occurs at the N terminus; it does not involve the 26 S proteasome, nor could it be induced by conditional overexpression of the cyclin-dependent kinase inhibitor p27(Kip1). However, high cell densities lead to increased cyclin A(t) levels. Unlike full-length cyclin A, cyclin A(t) localizes to the cytoplasm, where it binds Cdk2. The data suggest that cyclin A processing occurs in vivo to yield an N-terminally truncated isoform by an unknown mechanism that is regulated by cell density. Differential subcellular localization may provide the first insights into the physiological role of cyclin A(t).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11402021     DOI: 10.1074/jbc.M005452200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  2 in total

1.  Inverse relationship between TCTP/RhoA and p53 /cyclin A/actin expression in ovarian cancer cells.

Authors:  Malgorzata Kloc; Neelam Tejpal; Jitinderpal Sidhu; Malathesha Ganachari; Pedro Flores-Villanueva; Nicholas B Jennings; Anil K Sood; Jacek Z Kubiak; Rafik M Ghobrial
Journal:  Folia Histochem Cytobiol       Date:  2012-10-08       Impact factor: 1.698

2.  An intron-retaining splice variant of human cyclin A2, expressed in adult differentiated tissues, induces a G1/S cell cycle arrest in vitro.

Authors:  Arata Honda; Yannick Valogne; Myriam Bou Nader; Christian Bréchot; Jamila Faivre
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.